Skip to main content

Thermo Fisher Scientific Inc (TMO) Stock Analysis

Falling Knife setup

SellModerate Confidence

Healthcare · Diagnostics & Research

Sell if holding. Momentum 1.3/10 is below the 5.0 floor at $472.19 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum.

Thermo Fisher Scientific serves science through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. It generates revenue from instruments, reagents, consumables, and pharmaceutical services... Read more

$472.19+19.1% A.UpsideScore 5.2/10#13 of 25 Diagnostics & Research
Stop $441.93Target $558.49(analyst − 10%)A.R:R 2.7:1
Analyst target$620.54+31.4%24 analysts
$558.49our TP
$472.19price
$620.54mean
$750

Sell if holding. Momentum 1.3/10 is below the 5.0 floor at $472.19 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum. Chart setup: Death cross, below all MAs, RSI 40, MACD bearish. Score 5.2/10, moderate confidence.

Passes 6/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news boost analyst 0.40, earnings proximity 83d clear, semi cycle peak clear). Fails on weak momentum. Suitability: moderate.

Val5.7Qual5.8Grw4.2Mom1.3Sent8.2Ins5.0Peer3.7Tech7.0Risk6.45.2OVERALL

Thesis

Rewards
Strong earnings beat streak (4/4)
Recent Analyst detected in news
Risks
Negative momentum

Key Metrics

P/E (TTM)25.6
P/E (Fwd)17.1
Mkt Cap$173.3B
EV/EBITDA18.9
Profit Mgn15.2%
ROE13.5%
Rev Growth6.2%
Beta0.97
Dividend0.38%
Rating analysts35

Quality Signals

Piotroski F8/9

Options Flow

P/C0.74neutral
IV43%normal
Max Pain$360-23.8% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Volume
0.0
Obv
1.0
Ma Position
2.2
Rsi
3.5
Volume distribution (falling OBV)Below 200-MA but MA still rising (+2.4%/30d) — pullback in uptrend, not confirmed weakness

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
3.2
Value Rank
5.3
Quality Rank
6.4
GatesMomentum 1.3<4.5A.R:R 2.7 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS BOOST ANALYST 0.40EARNINGS PROXIMITY 83d clearSEMI CYCLE PEAK CLEARFalling KnifeSuitability: Moderate
RSI
40 · Neutral
↓ 20D MA↓ 50D MA↓ 200D MADEATH CROSSSupport $455.60Resistance $538.40

Price Targets

$442
$558
A.Upside+18.3%
A.R:R2.7:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Momentum score 1.3/10 — below 4.5 minimum

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-07-22 (83d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is TMO stock a buy right now?

Sell if holding. Momentum 1.3/10 is below the 5.0 floor at $472.19 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum. Chart setup: Death cross, below all MAs, RSI 40, MACD bearish. Prior stop was $441.93. Score 5.2/10, moderate confidence.

What is the TMO stock price target?

Take-profit target: $558.49 (+19.1% upside). Prior stop was $441.93. Stop-loss: $441.93.

What are the risks of investing in TMO?

Negative momentum.

Is TMO overvalued or undervalued?

Thermo Fisher Scientific Inc trades at a P/E of 25.6 (forward 17.1). TrendMatrix value score: 5.7/10. Verdict: Sell.

What do analysts say about TMO?

35 analysts cover TMO with a consensus score of 4.2/5. Average price target: $621.

What does Thermo Fisher Scientific Inc do?Thermo Fisher Scientific serves science through four segments: Life Sciences Solutions, Analytical Instruments,...

Thermo Fisher Scientific serves science through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. It generates revenue from instruments, reagents, consumables, and pharmaceutical services (manufacturing/clinical research) sold to pharmaceutical/biotech companies, hospitals, universities, and government agencies globally.

Related stocks: IQV (IQVIA Holdings, Inc.) · ILMN (Illumina, Inc.) · MTD (Mettler-Toledo International, I) · NTRA (Natera, Inc.) · DGX (Quest Diagnostics Incorporated)